Alexandre Hoctin
发表
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
Gabriela K. Fragiadakis,
2022,
Science immunology.
Siti Zubaidah Othman,
Karl Erik Müller,
Jose M. Mandei,
2021,
The Lancet Infectious Diseases.
Inserm,
Shana M Augustin,
C. Charpentier,
2020,
Clinical Microbiology and Infection.
C. A. Shaw,
Eglantine Ferrand Devouge,
Su Hwan Lee,
2022,
Critical Care.
N. Mahlaoui,
P. Frange,
T. Montange,
2021,
Frontiers in Immunology.
Siti Zubaidah Othman,
Eyvind W. Axelsen,
C. A. Shaw,
2022,
Influenza and other respiratory viruses.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
Karl Erik Müller,
Jose M. Mandei,
C. A. Shaw,
2021,
Infection.
V. Gaborieau,
A. Sommet,
R. Favory,
2021,
Fundamental & clinical pharmacology.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
Siti Zubaidah Othman,
C. A. Shaw,
Eglantine Ferrand Devouge,
2023,
Kidney International Reports.
Mark S. Anderson,
P. Gregersen,
R. Nussbaum,
2021,
Science Immunology.
Siti Zubaidah Othman,
Eyvind W. Axelsen,
C. A. Shaw,
2022,
Influenza and other respiratory viruses.
R. Tubiana,
P. Frange,
L. Mandelbrot,
2022,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
P. Gregersen,
2022,
Science Immunology.